Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney NSW 2050, Australia.
Neuroscience Research Australia, Sydney NSW 2031, Australia.
Molecules. 2017 Oct 19;22(10):1769. doi: 10.3390/molecules22101769.
α-Synuclein is a neuronal protein that is at the center of focus in understanding the etiology of a group of neurodegenerative diseases called α-synucleinopathies, which includes Parkinson's disease (PD). Despite much research, the exact physiological function of α-synuclein is still unclear. α-Synuclein has similar biophysical properties as apolipoproteins and other lipid-binding proteins and has a high affinity for cholesterol. These properties suggest a possible role for α-synuclein as a lipid acceptor mediating cholesterol efflux (the process of removing cholesterol out of cells). To test this concept, we "loaded" SK-N-SH neuronal cells with fluorescently-labelled cholesterol, applied exogenous α-synuclein, and measured the amount of cholesterol removed from the cells using a classic cholesterol efflux assay. We found that α-synuclein potently stimulated cholesterol efflux. We found that the process was dose and time dependent, and was saturable at 1.0 µg/mL of α-synuclein. It was also dependent on the transporter protein ABCA1 located on the plasma membrane. We reveal for the first time a novel role of α-synuclein that underscores its importance in neuronal cholesterol regulation, and identify novel therapeutic targets for controlling cellular cholesterol levels.
α-突触核蛋白是一种神经元蛋白,是理解一组称为 α-突触核蛋白病的神经退行性疾病病因的焦点,其中包括帕金森病(PD)。尽管进行了大量研究,但 α-突触核蛋白的确切生理功能仍不清楚。α-突触核蛋白具有与载脂蛋白和其他脂质结合蛋白相似的生物物理特性,并且对胆固醇具有高亲和力。这些特性表明 α-突触核蛋白可能作为脂质受体发挥作用,介导胆固醇外排(将胆固醇从细胞中去除的过程)。为了验证这一概念,我们将荧光标记的胆固醇“加载”到 SK-N-SH 神经元细胞中,然后添加外源性的 α-突触核蛋白,并使用经典的胆固醇外排测定法测量从细胞中去除的胆固醇量。我们发现 α-突触核蛋白能强烈刺激胆固醇外排。我们发现该过程呈剂量和时间依赖性,在 1.0 µg/mL 的 α-突触核蛋白时达到饱和。它还依赖于位于质膜上的转运蛋白 ABCA1。我们首次揭示了 α-突触核蛋白的一个新作用,强调了它在神经元胆固醇调节中的重要性,并确定了控制细胞胆固醇水平的新治疗靶点。